Skip to content

Exploratory analysis of gene profiling and immunohistochemical marker in male breast cancer.

Exploratory analysis of gene profiling and immunohistochemical marker in male breast cancer. - Exploratory analysis of gene profiling and immunohistochemical marker in male breast cancer.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000040660
Enrollment
100
Registered
2020-06-08
Start date
2020-05-20
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Male Breast Cancer

Interventions

None listed

Sponsors

National Center for Global Health and Medicine
Lead Sponsor

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: 1) Patients who have been diagnosed with male breast cancer 2) Patients who are 20 years of age or older at the time of diagnosis 3) Patients who have a sufficient quantity of specimens (approximately 30 4u thick unstained specimens) collected during the study period in question for measurement.

Exclusion criteria

Exclusion criteria: Patients who have decided inappropriate to include in this study by the investigators

Design outcomes

Primary

MeasureTime frame
Descriptive statistics of comprehensive gene panel analysis, BRCA1 gene methylation analysis, and immunohistochemical marker analysis of male breast cancer specimens

Countries

Japan

Contacts

Public ContactAkihiko Shimomura

National Center for Global Health and Medicine Breast and Medical Oncology

akshimomura@hosp.ncgm.go.jp03-3202-7181

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026